|
| Press Releases |
|
 |
|
| Tuesday, August 27, 2024 |
|
|
First Results From Lexaria's Second GLP-1 Human Pilot Study |
| more info >> |
|
| Thursday, August 22, 2024 |
|
|
Positive 8-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study |
| Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it has received and can now report on 8-week body weight results from ongoing animal study WEIGHT-A24-1 (the "Study"). more info >> |
|
| Wednesday, August 21, 2024 |
|
|
Positive Interim Blood Sugar Results From Lexaria's GLP-1 Diabetes Animal Study |
| Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it has received 4-week and 8-week blood glucose results from ongoing animal study WEIGHT-A24-1 (the "Study"). more info >> |
|
| Monday, August 19, 2024 |
|
|
Positive Results from Lexaria's Molecular Characterization Study Monomeric form of GLP-1 drug preserved by DehydraTECH |
| Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces positive findings from its applied research program together with the National Research Council of Canada ("NRC") that evaluated important mode of action facets of DehydraTECH processed with the glucagon-peptide 1 ("GLP-1") drug, semaglutide. more info >> |
|
| Monday, July 8, 2024 |
|
|
Lexaria Receives New Patents For Antiviral Drug Delivery and for Treating Epilepsy |
| Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces three new patent awards. more info >> |
|
| Wednesday, May 8, 2024 |
|
|
Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study |
| Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that human pilot study #2, GLP-1-H24-2, (the "Study") is underway and the first dosing visit for all nine study participants has already concluded. more info >> |
|
| Monday, May 6, 2024 |
|
|
Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs |
| Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 ("GLP-1") drug, semaglutide, related to its mode of action and performance. more info >> |
|
| Tuesday, April 16, 2024 |
|
|
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study |
| Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces approval has been received from an independent third-party ethics review board, for human pilot study #2 (the "Study"), investigating GLP-1 drugs and DehydraTECH. more info >> |
|
| Tuesday, April 2, 2024 |
|
|
Lexaria Awarded New Patents |
| more info >> |
|
| Thursday, March 14, 2024 |
|
|
Lexaria Appoints Nelson Cabatuan as Chief Financial Officer |
| Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of Nelson Cabatuan, CPA, as Chief Financial Officer (CFO) effective immediately. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Mainland China, Hong Kong, Macau companies triumph at finale of 2024 PropertyGuru Asia Property Awards 
Dec 18, 2024 08:00 HKT/SGT
|
|
|
The PropertyGuru Asia Real Estate Summit marks landmark 10th edition with aspirational discourses on future of cities
Dec 18, 2024 08:00 HKT/SGT
|
|
|
Outstanding resort projects, portfolios take centre stage at 2024 PropertyGuru Asia Property Awards (Japan)
Dec 18, 2024 02:00 HKT/SGT
|
|
|
TAC Security Becomes ioXt Authorized Lab, Expands into IoT Security Assessments
Dec 18, 2024 01:40 HKT/SGT
|
|
|
American Wave Machines Announces Partnership with China Tourism Group
Dec 17, 2024 23:06 HKT/SGT
|
|
|
Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience
Dec 17, 2024 22:10 HKT/SGT
|
|
|
GENERALIFX Unveils Multimillion-Dollar AI Strategy Autopilot to Revolutionize Trading
Dec 17, 2024 18:30 HKT/SGT
|
|
|
Q2 Metals Announces Final Analytical Results from the 2024 Drill Campaign at the Cisco Lithium Property, James Bay, Quebec, Canada, and Proceeds of $1.9 Million from Warrant Exercises
Dec 17, 2024 16:05 HKT/SGT
|
|
|
SRKay Consulting Group: Establishing a Global Capability Center in India
Dec 17, 2024 15:20 HKT/SGT
|
|
|
The Quantum Threat Is Here: Where Are We Quranium Releases Enterprise Quantum Readiness Survey Results
Dec 17, 2024 13:55 HKT/SGT
|
|
|
DENSO and onsemi Collaborate for a Strengthened Relationship
Dec 17, 2024 14:26 JST
|
|
|
Asian Financial Forum returns as Region's First Major International Financial Assembly in 2025
Dec 17, 2024 13:44 JST
|
|
|
West Air to Launch New International Route: Lhasa - Chongqing - Singapore on December 25, 2024
Dec 17, 2024 12:43 HKT/SGT
|
|
|
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY
Dec 17, 2024 10:58 HKT/SGT
|
|
|
Australian developers win at the 19th PropertyGuru Asia Property Awards Grand Final
Dec 17, 2024 10:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
